Backgrounds/Aims: Although perioperative therapies have improved greatly, pancreatectomies still often need blood transfusions. However, the morbidity from blood transfusions, the poor prognosis of blood transfused patients, high cost, and decreasing supply of blood products is accelerating transfusion-free (TF) surgery in the patients who have pacreatectomies. The aim of this study was to assess the feasibility of TF pancreatectomies for patients who are Jehovah's Witness. Methods: We investigated the possibility of TF pancreatectomies for the Jehovah's Witness patients undergoing pancreatectomies between January 2007 and Februay 2014. There were 4 cases of Whipple's operation, 4 of pylorus-preserving pancreaticoduodenectomy, 2 of radical antegrade modular pancreatosplenectomy and 1 of laparoscopic distal pancreatectomy. All were performed by one surgeon. Results: Most of the TF pancreatecomies patients received perioperative blood augmentation and intraoperative acute normovolemic hemodilution (ANH). They received no blood transfusions at any time during their hospitalization, and pre-and intra-operative data and outcomes were acceptably favorable. Conclusions: To the best of our knowledge, this report is the first successful consecutive pancreatectomy program for Jehovah's Witness not involving blood transfusion. TF pancreatectomy can be performed successfully in selected Jehovah's Witness. Postoperative prognosis and outcomes should be confirmed in follow up studies. 
INTRODUCTION
TF surgery has been gaining increased attention because of concern about viral infections. [1] [2] [3] [4] There has been a persistent lack of blood products, and the lack of alternatives products has promoted TF surgeries even in hepatobiliary surgery including liver transplantation. [5] [6] [7] [8] [9] Pancreatic surgery, itself, has a relatively high chance of transfusion risk compared to other types of surgery mainly because most pancreas operations require challenging and complex operative techniques. Over the past sev- 28.7%, total pancreatectomy 43.6%). 10 Recently, data for patients who underwent pancreatectomy and identified themselves as JW were published by the Memorial Sloan-Kettering Cancer Center. In that report, the median level of estimated blood loss (EBL) in the the pancreatectomies was 400 ml (range 250 to 1,800 ml). The findings showed that preoperative optimization of hemoglobin by blood augmentation achieved by intraoperative blood-conservation techniques, operative procedures minimizing blood loss and attentive postoperative care, permit the performance of major pancreatectomies in JW patients with good results. 11 In recent reports published in Korea, intraoperative transfusion was required in 57% of pancreaticoduodenectomies, 12 and 31% of laparoscopic pylorus-preserving pancreaticoduodenectomies.
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As mentioned above, although suitable non-TF techniques and materials have been developed, transfusion is still required in a substantial rumber of pancreatic operations. In this study, we report the clinical outcomes of the first successful program of pancreatectomies for JW patients suffering from pancreatic and peripancreatic lesions using a treatment algorithm for transfusion-refusing patients. of other diseases, and overall physiologic status. These many factors were analyzed in combination, but the analysis was subjective due to the absence of any certified scoring/weighting system for these parameters. After the extraction of blood had been completed, the patient's intravascular volume was restored with crystalloid solutions. Sometimes, colloid solutions was used in addition to crystalloid solutions. The patient's hemoglobin concentration was reduced to no lower than an acceptable minimum level based on physiologic status, bleeding risk factors, expected blood loss and medical considerations.
MATERIALS AND METHODS

Patients demographics
Because of the patients' religious beliefs, the ANH blood remained in the operation room without losing connection with the patient for 8 hours, to maintain platelet function.
The ANH blood was reinfused at the same rate as the other blood products. A relatively constant amount of blood was extracted for ANH, generally from 2 to 3 units depending on the expected blood loss, preoperative hemoglobin concentration, and the patient's overall physiologic status. Hemodynamic parameters including heart rate, blood pressure, arterial blood gas analysis, and central venous pressure were checked routinely by anesthsiologists during ANH to assess tolerance to the procedure. All the ANH blood which was harvested before the start of the operation was routinely reinfused just before the surgery was completed. ICS was not used throughout the procedure because of the possibility of contamination by cancer cells.
Surgical technique and postoperative care
Pylorus-preserving pancreaticoduodenectomy included the entire duodenum, gallbladder, common bile duct (CBD) and pancreas. The duodenum was transected from 2 centimeters distal from the pyloric ring to the end of the duodenum. The proximal cystic duct junction of the CBD and the gallbladder were included in the resection.
The pancreas was resected uncinate process, head and neck.
When resection margin invasion was suspected, frozen sections of multiple margin regions were also made. An end-to-side duct-to-mucosa type pancreaticojejunostomy (PJ) was performed. In the next stage, an end-to-side choledochojejunostomy (CJ) and side-to-side gastrojejunostomy (GJ) or an end-to-side duodeno-jejunostomy (DJ) was performed. The pancreatic duct was cannulated with an infant-feeding catheter and drained externally through the jejunum. Negative pressure was applied to the feeding tube for effective drainage of pancreatic juice. RAMPS procedure was done as described in detail previously. 15 The pancreas was transected at the neck. Then, the celiac lymph node was dissected. After lymph node dissection was complete, the posterior extent of the dissection required was decided on. Dissection was done to the level of the adrenal gland on the anterior and posterior planes. Laparoscopic distal pancreatectomy was performed with five trocars. After a pneumoperitoneum was made, the greater omentum was divided to allow entrance to the lesser sac. The pancreas was mobilized to visualize the proximal splenic artery and the superior mesenteric and splenic trunk. Then a space was identified behind the neck of the pancreas, and the pancreas was transected using that approach. The spleen was resected with the pancreas. 
Postoperative management
Definition of postoperative complications
Pancreatic fistula was diagnosed if there was more than 10 ml of drainage, and the amylase concentration of the drainage was three or more times the serum amylase concentration after postoperative day 10, following the International Study Group for Pancreatic Fistula (ISGPF) classification. 16 Biliary fisula was diagnosed as bilirubin-rich drainage of more than 50 ml per day or after the 10th postoperative day. Postoperative bleeding was defined as a decrease of hemoglobin concentration of more than 2 g/dl at 24 hours after surgery, or relaparotomy for bleeding control. 17 Abdominal abscess was defined when abnormal fluid collection was seen on abdominal CT scan, or the drainage was purulent. If nasogastric tube insertion was required after postoperative day 10, delayed gastric emptying was diagnosed. Lung complications were defined as any lung abnormality such as pneumonia, atelectasis, or pleural effusion on postoperative follow-up chest plain films. Table 1 presents patient demographics, tumor character- istics and baseline laboratory data. The mean age of the 11 patients was 62; six patients were female, three had hypertension, one had diabetes mellitus and another had chronic kidney disease. One patient had undergone earlier gastrointestinal surgery. Table 2 shows the types of operation for peripancreatic lesions performed. The curative operations for various diseases in this study were standard pancreaticoduodenectomy in four patients, PPPD in four patients, RAMPS in two patients, and laparoscopic distal pancreatectomy in one patient. Table 3 and Fig. 1 ANH was carried out in nine patients.
RESULTS
Postoperative complications occurred in 4 patients of the TF pancreatectomy patients ( On the other hand we performed consecutive TF pan- Second, the number of cases was too small to establish definitively that TF pancreatectomy is safe. Therefore, a large prospective study should be carried out. Third, the duration of the study was insufficient to demonstrate the oncologic effects of TF pancreatectomy in cancer patients.
Although our study has some limitations, it is, to the best of our knowledge, the first successful pancreatectomy program on selected patients in the form of a series of operations without blood transfusion.
In conclusion, if careful preoperative preparation and management is provided by a team approach, TF pancreatecmies can carried out successfully in selected patients without serious complications.
